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Introduction: Cardiac involvement is frequent in inﬂammatory myopathies. Electrocardio-
gram (ECG) may show evidence of this involvement and its changes should be well-known
and  described.
Objectives: Due to the lack of studies in the literature, we conducted an analysis of the ECG
ﬁndings in patients with dermatomyositis (DM) and polymyositis (PM), comparing them
with a control group.
Methods: This cross-sectional study compared the ECG of 86 individuals with no rheumatic
disorders (controls) with 112 patients (78 DM and 34 PM), during 2010–2013. The ECG ﬁndings
between DM and PM were also compared.
Results: Demographic characteristics, comorbidities and ECG abnormalities were similar
between controls and patients (p > 0.05), except for a higher frequency of left ventricular
hypertrophy (LVH) in patients (10.7% vs. 1.2%, p = 0.008). Demographic characteristics, comor-
bidities, clinical and laboratory manifestations, were also similar between the groups PM and
DM,  except for the presence of cutaneous lesions only in DM. One-third of the patients had
ECG  abnormalities, which were more prevalent in PM than DM (50% vs. 24.4%, p = 0.008).
LVH, left atrial enlargement, rhythm and conduction abnormalities were more  frequent in
PM  than DM (p < 0.05 for all), especially the left anterior fascicular block.
Conclusions: We  showed distinct ECG changes between DM and PM and a higher frequency
of  LVH in patients compared to controls. Investigation of cardiac involvement should be
considered even in asymptomatic patients, especially PM. Further studies are necessary in
order to determine the correlation of ECG ﬁndings with other complementary tests, clinicalmanifestations, disease activity and progression to other cardiac diseases.
© 2014 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author.
E-mail: samuel.shinjo@gmail.com (S.K. Shinjo).
ttp://dx.doi.org/10.1016/j.rbre.2014.08.012
255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
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Alterac¸ões  eletrocardiográﬁcas  em  dermatomiosite  e  polimiosite
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Introduc¸ão: Acometimento cardíaco nas miopatias inﬂamatórias é frequente. Eletrocardio-
grama (ECG) pode mostrar indícios desse acometimento e suas alterac¸ões devem ser bem
conhecidas e descritas.
Objetivos: Devido à escassez de trabalhos na literatura, analisamos as alterac¸ões de ECG em
pacientes com dermatomiosite (DM) e polimiosite (PM) e as comparamos com um grupo
controle.
Métodos: Este estudo transversal comparou ECGs de 86 indivíduos sem doenc¸as reumatológ-
icas  (controles) com 112 pacientes (78 DM e 34 PM), de 2010 a 2013. Também comparamos
os  ECGs entre DM e PM.
Resultados: Características demográﬁcas, comorbidades e alterac¸ões de ECG foram semel-
hantes entre controles e pacientes (p > 0,05), exceto pela maior frequência de sobrecarga de
ventrículo esquerdo (SVE) nos pacientes (10,7% vs. 1,2%; p = 0,008). Características demográ-
ﬁcas, comorbidades, manifestac¸ões clínicas e laboratoriais também foram semelhantes
entre os grupos PM e DM, exceto por lesões cutâneas apenas em pacientes com DM.  Um
terc¸o  dos pacientes apresentou alterac¸ões de ECG, que foram mais prevalentes em PM do
que  em DM (50% vs. 24,4%, p = 0,008). Sobrecarga de câmaras esquerdas (SCE), distúrbios do
ritmo e da conduc¸ão foram mais encontrados em PM do que em DM (p < 0,05 para todos),
sobretudo o bloqueio divisional do ramo anterossuperior.
Conclusões: Encontramos alterac¸ões distintas de ECG entre PM e DM e frequência aumentada
de  SVE em pacientes quando comparados com controles. Investigac¸ão do acometimento
cardíaco nessas doenc¸as deve ser considerada mesmo em pacientes assintomáticos, espe-
cialmente em se tratando de PM. Mais estudos são necessários para correlacionar os achados
de  ECG com outros exames complementares, manifestac¸ões clínicas, atividade das miopa-
tias e evoluc¸ão para outras doenc¸as cardíacas.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Dermatomyositis (DM) and polymyositis (PM) are immune-
mediated inﬂammatory disorders characterized by the
presence of progressive proximal muscle weakness of
limbs. In DM,  typical skin changes, such as heliotrope
and/or Gottron sign, still occur. Furthermore, extramuscular
manifestations such as joint, cardiopulmonary and gastroin-
testinal tract involvement can also be present in these
diseases.1,2
In particular, cardiac involvement in idiopathic inﬂamma-
tory myopathies can occur in 9–72% of cases, depending on
the diagnostic method used and selection of patients.3–6
Among patients with cardiac involvement, the clinical
manifestations are infrequent and, when present, are mainly
related to congestive heart failure.6,7 In contrast, the vast
majority of patients are asymptomatic and characterized
especially by changes in the conduction system, hypertrophy
and dilatation of the heart chambers and diastolic left ventri-
cular dysfunction.4,5
To date, there are few studies in the literature specif-
ically assessing changes in the electrocardiogram (ECG) in
idiopathic inﬂammatory myopathies.3–5,7–13 When they exist,
are essentially limited to vague and brief descriptions of
electrocardiographic ﬁndings in this population.7,9,10,12,13 Fur-
thermore, none of these studies7,9,10,12,13 presented a controlgroup, nor examined systematically and comparatively possi-
ble electrocardiographic abnormalities found in patients with
DM and PM, which motivated us to conduct this study.
Materials  and  methods
This is a cross-sectional, single-center study. One hundred and
twelve consecutive patients with DM and PM were evaluated
according to the criteria of Bohan and Peter14,15 in the period
between 2010 and 2013, and followed at our department.
No patients with amyopathic DM, inﬂammatory myopathies
associated with other collagen diseases, malignancies or other
causes of myopathy were included. As a control group, 86 out-
patient subjects with no history of rheumatic disease were
selected. All participants of this study were aged ≥18 years, did
not use antiarrhythmogenic drugs nor had a history of angina,
palpitations, myocardial infarction, heart failure, valvular dis-
ease and/or hyperthyroidism.
The study was approved by the local Ethics Committee [HC
0039/10].
Clinical and laboratory data of patients with DM and PM
were obtained from a systematic review of the electronic
medical record with previously parameterized and stan-
dardized data, including those of interest for the present
study. The parameters analyzed were: disease duration and
mean age at the time of performing ECG; gender; clinical
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anifestations (constitutional symptoms, dysphagia, joint
nvolvement [arthritis and/or arthralgia]); pulmonary involve-
ent (conﬁrmed by computed tomography: presence of
nterstitial lung disease, “ground-glass” or honeycombing
esions); skin changes (heliotrope, Gottron papules, ulcers,
alcinosis, cutaneous vasculitis, V-sign, shawl sign); labo-
atory abnormalities (serum creatine phosphokinase [CPK],
ith a reference value of 24–173 U/L obtained by an auto-
ated kinetic method; antinuclear factor assessed by indirect
mmunoﬂuorescence using Hep-2 cells as substrate, anti-Jo-1
ntibody by immunoblotting method).
Demographic data and comorbidities (hypertension, dia-
etes mellitus and hypothyroidism) of all participants were
lso obtained.
A resting 12-Lead ECG was ordered to all patients for
his study; these tests were performed and analyzed at the
Table 1 – Demographic and clinical data and comorbidities (der
group.
Control (n = 86) 
Mean age (years) 49.0 ± 15.3 
Female gender 70 (69.0) 
Disease duration (years) – 
Comorbidities
Hypothyroidism 10 (11.9) 
Hypertension 31 (36.9) 
Diabetes mellitus 16 (19.0) 
Electrocardiographic changes 30 (35.8) 
1 item (A, B, C or D) 26 (31.0) 
2 items (A, B, C or D) 4 (4.8) 
3 items (A, B, C or D) 0 
4 items (A, B, C and D) 0 
(A) Rhythm changes 7 (8.1) 
Ventricular extrasystole 2 (2.4) 
Sinus arrhythmia 0 
Atrial ﬁbrillation 1 (1.2) 
Atrial ectopic rhythm 0 
First-degree A-V block 2 (2.4) 
Supraventricular tachycardia 0 
Supraventricular extrasystole 2 (2.4) 
Change of 1 sub-item of A 7 (8.3) 
Change of 2 sub-items of A 0  
Change of 3 or more sub-items of A 0 
(B) Chamber hypertrophy 3 (3.6) 
Left ventricular 1 (1.2) 
Right ventricular 0 
Left atrial 2 (2.4) 
Right atrial 0 
Change of 1 sub-item of B 3 (3.6) 
Change of 2 sub-items of B 0 
Change of 3 or more sub-items of B 0 
(C) Conduction disturbance 6 (7.1) 
ASDBB 4 (4.8) 
RBBB 1 (1.2) 
LBBB 1 (1.2) 
Change of 1 sub-item of C 6 (7.1) 
Change of 2 sub-items of C 0 
Change of 3 or more sub-items of C 0 
(D) DVRC 18 (21.4) 
DVRC, diffuse ventricular repolarization changes; A-V, atrioventricular; A
branch block; LBBB, left bundle branch block; DM, dermatomyositis; PM, p 1 6;5  6(2):95–100 97
Service of Electrocardiology in the same Institute. The con-
trol group consisted of sequential individuals who  had an
ECG performed in the same service, mostly in the preoper-
ative workup of non-vascular/cardiac surgery. The following
electrocardiographic changes were analyzed in the study:
rhythm disturbances (ventricular extrasystole, sinus arrhyth-
mia, atrial ﬁbrillation, atrial ectopic rhythm, supraventricu-
lar tachycardia, atrioventricular block and supraventricular
extrasystoles), chamber hypertrophy (left and right ventricles,
left and right atria), conduction abnormalities (right bundle
branch block [RBBB], left bundle branch block [LBBB], anterosu-
perior divisional branch block [ASDBB]) and diffuse ventricular
repolarization changes (DVRC). The changes found were com-
pared among control, PM and DM groups.
Results were expressed as mean ± standard deviation (SD),
median [25–75% interquatiles] or percentage (%). For statistical
matomyositis and polymyositis) of patients and control
DM/PM (n = 112) *p
48.9 ± 15.4 0.944
80 (71.4) 0.923
5 [2–12] –
15 (13.4) 0.877
51 (45.5) 0.231
17 (15.2) 0.654
36 (32.1) 0.761
29 (25.9) 0.525
5 (4.5) 1.000
2 (1.8) –
0 1.000
12 (28.6) 0.631
3 (2.7) 1.000
3 (2.7) –
1 (0.9) 1.000
2 (1.8) –
3 (2.7) 1.000
1 (0.9) –
1 (0.9) 1.000
10 (8.9) 1.000
2 (1.8) –
0 1.000
13 (11.6) 0.063
12 (10.7) 0.008
0 1.000
5 (4.5) 0.607
0 1.000
9 (8.0) 0.237
4 (3.6) –
0 1.000
6 (16.0) 0.766
5 (4.5) 1.000
1 (0.9) 1.000
1 (0.9) 1.000
5 (4.5) 0.766
1 (0.9) –
0 1.000
14 (12.5) 0.161
SDBB, anterosuperior divisional branch block; RBBB, right bundle
olymyositis.
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Table 2 – Demographic and clinical data and comorbidities of patients with dermatomyositis and polymyositis.
Total (n = 112) DM (n = 78) PM (n = 34) ap
Mean age (years) 48.9 ± 15.4 49.1 ± 15.9 48.3 ± 14.3 0.789
Female gender 80 (71.4) 58 (74.4) 22 (64.7) 0.298
Disease duration (years) 5 [2–12] 6 [3–15] 4 [1–10] 0.121
Clinical manifestations
Constitutional symptoms 27 (24.1) 19 (24.4) 8 (23.5) 0.565
Dysphagia 27 (24.1) 20 (25.6) 7 (20.6) 0.329
Joint involvement 46 (41.1) 31 (39.7) 15 (44.1) 0.661
Pulmonary involvement 37 (33.0) 28 (35.9) 9 (26.5) 0.329
Skin lesions
Heliotrope 65 (58.0) 65 (83.3) 0 –
Gottron’s papules 73 (65.2) 73 (93.6) 0 –
Ulcers 32 (28.6) 8 (10.3) 0 –
Calcinosis 10 (8.9) 10 (12.8) 0 –
Cutaneous vasculitis 11 (9.8) 11 (14.1) 0 –
V sign 9 (8.0) 9 (11.5) 0 –
Shawl sign 3 (2.7) 3 (3.8) 0 –
Laboratory abnormalities
Initial CPK (U/L) 723 [244–4012] 533 [170–3748] 2076 [728–4868] 0.221
Antinuclear factor 49 (43.8) 36 (46.2) 13 (38.2) 0.437
Anti-Jo-1 antibody 8 (7.1) 4 (5.1) 4 (11.8) 0.261
Comorbidities
Hypothyroidism 15 (13.4) 10 (12.8) 5 (14.7) 0.770
Hypertension 51 (45.5) 37 (47.4) 14 (41.2) 0.541
Diabetes mellitus 17 (15.2) 10 (12.8) 7 (20.6) 0.390
is.
ositisCPK, creatine phosphokinase; DM, dermatomyositis; PM, polymyosit
a Comparison between patients with polymyositis and dermatomy
analysis, Student’s t and Mann–Whitney tests for continuous
variables and chi-squared or Fisher’s exact test for categorical
data were used. These calculations were performed with the
computer program STATA version 7.0 (STATA, College Station,
TX, USA). p-Values < 0.050 were considered statistically signif-
icant.
Results
The general characteristics of the 112 patients (DM and PM)
and of the control group (n = 86) are presented in Table 1.
Demographic data and comorbidities were similar in both
groups (p > 0.05). The ECG ﬁndings were also similar, except
for a higher frequency of left ventricular hypertrophy (LVH) in
patients when compared to the control group (10.7% vs. 1.2%,
p = 0.008). Changes of rhythm were more  frequent in patients
versus controls, but without statistical signiﬁcance (28.6% vs.
8.1%, p = 0.631).
An additional analysis comparing 78 DM and 34 PM
patients will be presented in Table 2. Patients with DM and PM
were comparable regarding demographic, clinical and labora-
tory data and also as to comorbidities, except for the presence
of skin lesions only in patients with DM.
One-third of the patients had electrocardiographic abnor-
malities (Table 3), which included rhythm disturbances
(ventricular extrasystole, sinus arrhythmia, atrial ﬁbrillation,
ectopic atrial rhythm, ﬁrst-degree AV block, supraventric-
ular tachycardia, supraventricular extrasystoles), chamber
hypertrophy (atrium and left ventricles) and conduction
disturbances (ASDBB, RBBB and LBBB) and DVRC. The presence.
of changes was found more  frequently in patients with PM
when compared to patients with DM (50% vs. 24.4%, p = 0.008).
More than a change of ECG per patient was observed only in
PM group, and no cases have been reported in patients with
DM. None of the study participants showed right-chamber
changes.
The frequency of rhythm disturbances and chamber over-
load were higher in patients with PM compared to those
with DM (p = 0.007 and p = 0.003, respectively), and both LVH
and left atrium hypertrophy were predominant in patients
with PM (p = 0.007 and p = 0.029, respectively) (Table 3). Atrial
ﬁbrillation, supraventricular extrasystoles and ﬁrst-degree
atrioventricular block were observed only in patients with
PM, and no case have been reported in patients with DM.
Supraventricular tachycardia was observed only in one case
in the entire study, in a patient with DM.
Conduction disorders also were more  frequent in patients
with PM (p = 0.010), with emphasis for ASDBB (p = 0.029). No
patient had RBBB or LBBB in the DM group compared to a case
of each in PM group.
Discussion
In the present study, we analyzed the electrocardiographic
changes (rhythm, chamber hypertrophy and conduction) in
a large case series of patients with DM and PM,  compared
to a control group. Our results showed that the frequency of
ECG changes in patients with DM and PM was similar to that
observed in the control group, except for a higher prevalence
of LVH in our patients. Further analysis showed that changes
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Table 3 – Demographic, clinical and laboratory data and comorbidities of patients with dermatomyositis and
polymyositis.
Total (n = 112) DM (n = 78) PM (n = 34) p
Electrocardiographic changes 36 (32.1) 19 (24.4) 17 (50.0) 0.008
1 item (A, B, C or D) 29 (25.9) 19 (24.4) 10 (29.4) 0.367
2 items (A, B, C or D) 5 (4.5) 0 5 (14.7) –
3 items (A, B, C or D) 2 (1.8) 0 2 (5.9) –
4 items (A, B, C and D) 0 0 0 1.000
(A) Rhythm changes 12 (28.6) 4 (5.1) 8 (23.5) 0.007
Ventricular extrasystole 3 (2.7) 1 (1.3) 2 (5.9) 0.166
Sinus arrhythmia 3 (2.7) 2 (2.6) 1 (2.9) 1.000
Atrial ﬁbrillation 1 (0.9) 0 1 (2.9) 0.304
Atrial ectopic rhythm 2  (1.8) 1 (1.3) 1 (2.9) 0.517
First-degree A-V block 3 (2.7) 0 3 (8.8) –
Supraventricular tachycardia 1 (0.9) 1 (1.3) 0 –
Supraventricular extrasystole 1 (0.9) 0 1 (2.9) –
Change of 1 sub-item of A 10 (8.9) 3 (3.8) 7 (20.6) 0.008
Change of 2 sub-items of A 2 (1.8) 1 (1.3) 1 (2.9) 0.517
Change of 3 or more sub-items of A 0 0 0 1.000
(B) Chamber hypertrophy 13 (11.6) 4 (5.1) 9 (26.5) 0.003
Left ventricular 12 (10.7) 4 (5.1) 8 (23.5) 0.007
Right ventricular 0 0 0 1.000
Left atrial 5 (4.5) 1 (1.3) 4 (11.8) 0.029
Right atrial 0 0 0 1.000
Change of 1 sub-item of B 9 (8.0) 3 (3.8) 6 (17.6) 0.022
Change of 2 sub-items of B 4 (3.6) 1 (1.3) 3 (8.8) 0.083
Change of 3 or more sub-items of B 0 0 0 1.000
(C) Conduction disturbance 6 (16.0) 1 (1.3) 5 (14.7) 0.010
ASDBB 5 (4.5) 1 (1.3) 4 (11.8) 0.029
RBBB 1 (0.9) 0 1 (2.9) –
LBBB 1 (0.9) 0 1 (2.9) –
Change of 1 sub-item of C 5 (4.5) 1 (1.3) 4 (11.8) 0.029
Change of 2 sub-items of C 1 (0.9) 0 1 (2.9) 1.000
Change of 3 or more sub-items of C 0 0 0 1.000
(D) DVRC 14 (12.5) 10 (12.8) 4 (11.8) 1.000
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n ECG were found in most patients with PM, when compared
o patients with DM,  especially for the higher frequency of left
hamber hypertrophy, changes of rhythm and the presence of
SDBB in the ﬁrst group.
So far, there are few studies evaluating electrocardio-
raphic changes in patients with DM and PM; and, when
resent, these are limited to a small number of cases and/or
n the absence of a control group,7,9,10,12,13 differently of
he present study. ECG changes in idiopathic inﬂammatory
yopathies occur in 33–72%.3–5,7–13
Our data show that LVH was signiﬁcantly present in
atients with DM and PM compared to the control group. Fur-
hermore, an additional analysis showed the persistence of
eft-chamber hypertrophy in patients with PM,  when com-
ared to patients with DM.  This ﬁnding could be explained
y the high prevalence of systemic hypertension, commonly
ound in patients with DM and PM,16,17 although this ﬁnd-
ng was similar to the prevalence in the control group. It is
ecessary, however, to evaluate the duration and degree of
ypertension in these individuals, as well as their blood pres-
ure control. And the pathogenesis of DM and PM itself also
ay have contributed to left chamber hypertrophy. There are
ndications of presence of inﬁltration of mononuclear inﬂam-
atory cells in the endomysium and in perivascular areasSDBB, anterosuperior divisional branch block; RBBB, right bundle
olymyositis.
of infarction, as well as degeneration of cardiac myocytes
and areas of myocardial ﬁbrosis.12,13,18,19 This inﬂammatory
process in the myocardium can lead to remodeling, with
anatomical and functional changes of the myocardium and,
ultimately, possible left ventricular dysfunction and restrictive
cardiomyopathy and heart failure. Thus, ECG changes may be
an early ﬁnding of these complications.
Corroborating our data, Sharratt et al.10 showed that 5 of
13 patients with PM had cardiac abnormalities seen by clini-
cal examination, ECG and/or chest radiography. Of these ﬁve,
four patients had abnormalities of left ventricular dysfunc-
tion, diagnosed by ECG. On the other hand, Gonzalez-Lopez
et al.4 observed in a case series of 32 patients the presence of
diastolic dysfunction of left ventricle in 42% of cases. Schwartz
et al.11 compared 59 patients with juvenile DM with 59 healthy
subjects and observed that only their patients had subclini-
cal diastolic (left ventricular) dysfunction, showing that such
change is inherent to the disease (juvenile DM).
Regarding the changes of rhythm and conduction disor-
ders, there was no signiﬁcant difference between patients and
the control group analyzed in this study. However, when com-
paring patients with DM and patients with PM, there was
a higher frequency of disturbances of rhythm and conduc-
tion, especially ASDBB, in patients with PM.  Previous studies
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with ECG and Holter monitoring in patients with DM and PM
showed several abnormalities in this population: atrial and
ventricular extrasystoles, atrial tachycardia, ventricular tachy-
cardia, atrial ﬁbrillation, atrioventricular conduction block,
bundle branch blocks, abnormal Q waves  and nonspeciﬁc ST-T
segment changes.3,4,6,7
In studies with autopsy, histological changes were found in
the conduction system, with the presence of lymphocyte inﬁl-
tration and sinoatrial node ﬁbrosis,18,19 which may explain the
presence of conduction ﬁndings in patients with idiopathic
inﬂammatory myopathies.
Our study has limitations, by not presenting a structural
cardiac evaluation nor an assessment for myocardium inﬂam-
mation. However, as the cardiac involvement is a factor of
worse prognosis for patients with myopathies,20 the ECG may
serve as a noninvasive, cheap and practical tool for an ini-
tial assessment and in tracking this problem. Another limiting
factor is the failure to establish a correlation of ECG ﬁndings,
particularly with disease activity (DM/PM). Furthermore, we
must consider that the lack of electrocardiographic differences
between patients and controls may also be due to a selec-
tion bias, since the control group came from the preoperative
(and clinical) sector, with a frequency of comorbidities similar
to that of our patients and perhaps with a higher frequency
of electrocardiographic changes versus healthy subjects. How-
ever, we  believe that this bias is not signiﬁcant, due to the fact
that most ECGs in control group were performed on patients
involved in preoperative non-cardiac/vascular surgery.
In summary, we  observed a higher frequency of LVH in
patients with inﬂammatory myopathies. Furthermore, there
was a distinction of the ECG ﬁndings between patients with
DM and PM,  with higher prevalence of left-chamber hypertro-
phy and rhythm and conduction disturbances in patients with
PM compared to DM.
More  studies are needed to determine the correlation of
ECG ﬁndings with other complementary tests, clinical man-
ifestations, myopathy activity and evolution to other cardiac
diseases.
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